{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:46:25Z","timestamp":1790876785332,"version":"4.1.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.autrev.2024.103611","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T22:36:03Z","timestamp":1724798163000},"page":"103611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence"],"prefix":"10.1016","volume":"23","author":[{"given":"Alvaro J.","family":"Vivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Synda","family":"Boumediene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J.","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103611_bb0005","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.jtauto.2021.100130","article-title":"Cell function in autoimmune disease","volume":"4","author":"Rajendeeran","year":"2021","journal-title":"J Transl Autoimmun [Internet]"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0010","article-title":"SVM-Based Model Combining Patients\u2019 Reported Outcomes and Lymphocyte Phenotypes of Depression in Systemic Lupus Erythematosus","volume":"13","author":"Dong","year":"2023","journal-title":"Biomolecules [Internet]"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","article-title":"The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis","volume":"44","author":"Matcham","year":"2014","journal-title":"Semin Arthri Rheum [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/13696998.2023.2194185","article-title":"Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies","volume":"26","author":"Alvarez","year":"2023","journal-title":"J Med Econ [internet]"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043522","article-title":"Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry","volume":"20","author":"Wang","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.autrev.2024.103611_bb0030","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol [Internet]"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1051\/medsci\/20173302012","article-title":"Pr\u00e9disposition aux pathologies auto-immmunes","volume":"33","author":"Dragin","year":"2017","journal-title":"Medecine\/Sciences"},{"issue":"10391","key":"10.1016\/j.autrev.2024.103611_bb0040","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0045","article-title":"Therapeutic plasma exchange as a treatment for autoimmune neurological disease","volume":"2020","author":"Nieto-Aristiz\u00e1bal","year":"2020","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2024.103611_bb0050","doi-asserted-by":"crossref","first-page":"102870","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J Autoimmun [Internet]"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0961203320988586","article-title":"A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: launching the GLADEL 2.0 study group","volume":"30","author":"G\u00f3mez-Puerta","year":"2021","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2019.1660028","article-title":"A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today\u2019s treatment options","volume":"30","author":"Yamanaka","year":"2020","journal-title":"Mod Rheumatol [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2024.103611_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2018.00515","article-title":"Predicting diabetes mellitus with machine learning techniques","volume":"9","author":"Zou","year":"2018","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/make5010013","article-title":"Machine learning and prediction of infectious diseases: a systematic review","volume":"5","author":"Santangelo","year":"2023","journal-title":"Mach Learn Knowl Extr"},{"key":"10.1016\/j.autrev.2024.103611_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2024.103611_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mehy.2019.01.021","article-title":"Frontal fibrosing alopecia: a new autoimmune entity?","volume":"124","author":"Garcia-Robledo","year":"2019","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.autrev.2024.103611_bb0090","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s10067-021-05888-0","article-title":"Is fibromyalgia an autoimmune illness?","volume":"40","author":"Mart\u00ednez-Lav\u00edn","year":"2021","journal-title":"Clin Rheumatol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.930970","article-title":"Can antinuclear antibodies have a pathogenic role in systemic sclerosis?","volume":"13","author":"Chepy","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2024.103611_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5114\/reum.2018.77976","article-title":"Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications","volume":"56","author":"Grygiel-G\u00f3rniak","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.autrev.2024.103611_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/5476903","article-title":"New biomarkers in autoimmune disease","volume":"2017","author":"Shi","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103611_bb0115","first-page":"1","article-title":"Introduction to machine learning, neural networks, and deep learning","volume":"9","author":"Choi","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.autrev.2024.103611_bb0120","article-title":"Deep learning for epidemiologists: an introduction to neural networks","volume":"85250","author":"Serghiou","year":"2023","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.autrev.2024.103611_bb0125","series-title":"Data Mining and Knowledge Discovery Handbook","first-page":"257","article-title":"Support vector machines","author":"Shmilovici","year":"2005"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.beth.2020.05.002","article-title":"Supervised machine learning: a brief primer","volume":"51","author":"Jiang","year":"2020","journal-title":"Behav Ther [Internet]"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat Rev Rheumatol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0140","first-page":"1","article-title":"Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00978-5","article-title":"T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update","volume":"23","author":"Chen","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1165\/rcmb.2023-0327ED","article-title":"Pleural fibrosis: now That\u2019s what mTORC (ing) about","volume":"70","author":"Mutsaers","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0160","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg cell differentiation and function by the Interleukin-21\u2013mechanistic target of rapamycin Axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0170","first-page":"15","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation","volume":"15","author":"Huang","year":"2024","journal-title":"Nat Commun"},{"issue":"349","key":"10.1016\/j.autrev.2024.103611_bb0175","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of auto-antibodies before the clinical onset of systemic lupus erythematosus","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med [Internet]"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0180","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/art.20120","article-title":"The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus","volume":"50","author":"McClain","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0190","first-page":"1092","article-title":"Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals","volume":"61","author":"Mu\u00f1oz-Grajales","year":"2022","journal-title":"Rheumatol (United Kingdom)"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0195","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103611_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8051972","article-title":"Hypocomplementemia as a risk factor for organ damage accrual in patients with systemic lupus erythematosus","volume":"2018","author":"Raymond","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103611_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103611_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.593610","article-title":"How does complement affect hematological malignancies: from basic mechanisms to clinical application","volume":"11","author":"Luo","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0215","first-page":"2","article-title":"Hypocomplementemic urticarial Vasculitis associated with Hashimoto\u2019s thyroiditis and hepatitis B virus infection: a case report","volume":"14","author":"Scurtu","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/lupus-2014-000056","article-title":"Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements","volume":"1","author":"Putterman","year":"2014","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.41093","article-title":"Complement activation in patients with probable systemic lupus erythematosus and ability to predict progression to American College of Rheumatology\u2013Classified Systemic Lupus Erythematosus","volume":"72","author":"Ramsey-Goldman","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0230","doi-asserted-by":"crossref","first-page":"105556","DOI":"10.1016\/j.jbspin.2023.105556","article-title":"Predicting the onset of rheumatoid arthritis","volume":"90","author":"Gilbert","year":"2023","journal-title":"Jt Bone Spine"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2024.103611_bb0240","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic Citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0245","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ard.2006.062919","article-title":"Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis","volume":"66","author":"Koivula","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10113017","article-title":"Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies","volume":"10","author":"Mueller","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070657","article-title":"Post-translational modifications of proteins: Novel insights in the autoimmune response in rheumatoid arthritis","volume":"8","author":"Carubbi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103611_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00192","article-title":"Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis","volume":"6","author":"Pruijn","year":"2015","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0265","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39297","article-title":"Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease","volume":"67","author":"Ramos-Remus","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0270","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.40880","article-title":"A prospective study of the development of inflammatory arthritis in the family members of indigenous north American people with rheumatoid arthritis","volume":"71","author":"Tanner","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0275","first-page":"554","article-title":"Seronegative rheumatoid arthritis: one year in review 2023","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0280","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb0285","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/art.40237","article-title":"Association of the Presence of anti-Carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR cohort","volume":"69","author":"Truchetet","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0536-2","article-title":"Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage","volume":"17","author":"Brink","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0295","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.27570","article-title":"Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis","volume":"62","author":"Kolfenbach","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0300","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"Beaart-Van De Voorde LJJ, Brouwer E, Codreanu C, Combe B, et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"Van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0305","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-019-04855-0","article-title":"EULAR definition of \u201carthralgia suspicious for progression to rheumatoid arthritis\u201d in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound","volume":"39","author":"Ruta","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"16","key":"10.1016\/j.autrev.2024.103611_bb0310","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2169\/internalmedicine.0077-22","article-title":"Predictive value of magnetic resonance imaging-detected tenosynovitis of the metacarpophalangeal and wrist joints for the development of rheumatoid arthritis among patients with undifferentiated arthritis","volume":"62","author":"Tamai","year":"2023","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02405-7","article-title":"Serum biomarker panel for the diagnosis of rheumatoid arthritis","volume":"23","author":"Mun","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1172\/JCI115573","article-title":"Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus","volume":"89","author":"Kaufman","year":"1992","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0325","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00125-019-4874-5","article-title":"Perinatal risk factors for type 1 diabetes revisited: a population-based register study","volume":"62","author":"Waernbaum","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2024.103611_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00343","article-title":"T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.autrev.2024.103611_bb0335","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrneph.2017.138","article-title":"B cells in type 1 diabetes mellitus and diabetic kidney disease","volume":"13","author":"Smith","year":"2017","journal-title":"Nat Rev Nephrol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0340","doi-asserted-by":"crossref","first-page":"106792","DOI":"10.1016\/j.phrs.2023.106792","article-title":"Lessons and gaps in the prediction and prevention of type 1 diabetes","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol Res [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0345","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0350","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0355","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.xcrm.2023.101116","article-title":"Plasma protein biomarkers trailblaze as early predictors of type 1 diabetes","volume":"4","author":"Jia","year":"2023","journal-title":"Cell Reports Med [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0365","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2337\/dc21-0602","article-title":"CGM metrics predict imminent progression to type 1 diabetes: autoimmunity screening for kids (ASK) study","volume":"45","author":"Steck","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051459","article-title":"Role of viral infections in the pathogenesis of sj\u00f6gren\u2019s syndrome: Different characteristics of epstein-barr virus and htlv-1","volume":"9","author":"Nakamura","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000622","article-title":"The role of Epstein\u2013Barr virus infection in primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Ma\u015bli\u0144ska","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"23","key":"10.1016\/j.autrev.2024.103611_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20235861","article-title":"New viral facets in oral diseases: the EBV paradox","volume":"20","author":"Tonoyan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103611_bb0385","doi-asserted-by":"crossref","first-page":"105443","DOI":"10.1016\/j.meegid.2023.105443","article-title":"T cell-mediated immunity during Epstein\u2013Barr virus infections in children","volume":"112","author":"Liu","year":"2023","journal-title":"Infect Genet Evol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0390","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11080831","article-title":"CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases","volume":"11","author":"Ruiz-Pablos","year":"2022","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0400","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial\u2013immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0405","first-page":"1","article-title":"Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar","volume":"11","author":"Haris","year":"2021","journal-title":"Sci Rep [Internet]"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0410","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060738","article-title":"Salivary proteomics markers for Preclinical Sj\u00f6gren\u2019s syndrome: a pilot study","volume":"12","author":"Di Giorgi","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diagnostics11010071","article-title":"Tear atg5 as a potential novel biomarker in the diagnosis of sj\u00f6gren syndrome","volume":"11","author":"Byun","year":"2021","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0425","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5606\/ArchRheumatol.2017.6273","article-title":"Beta-2 microglobulin in whole unstimulated saliva can effectively distinguish between sj\u00f6gren\u2019s syndrome and non-autoimmune sicca symptoms","volume":"32","author":"Riega-Torres","year":"2017","journal-title":"Arch Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0430","first-page":"182","article-title":"Salivary B2-microglobulin positively correlates with ESSPRI in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"57","author":"Garza-Garc\u00eda","year":"2017","journal-title":"Rev Bras Reumatol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0435","doi-asserted-by":"crossref","first-page":"795","DOI":"10.55563\/clinexprheumatol\/gy6udz","article-title":"Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Mona","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103611_bb0440","doi-asserted-by":"crossref","first-page":"30039","DOI":"10.18632\/oncotarget.15613","article-title":"Investigation of three potential autoantibodies in Sjogren\u2019s syndrome and associated MALT lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2024.103611_bb0445","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2019.03.008","article-title":"Soluble siglec-5 is a novel salivary biomarker for primary Sjogren\u2019s syndrome","volume":"100","author":"Lee","year":"2019","journal-title":"J Autoimmun [Internet]"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0450","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2015.33","article-title":"Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mohan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2024.103611_bb0455","first-page":"1","article-title":"Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease","volume":"12","author":"Ban","year":"2021","journal-title":"Nat Commun [Internet]"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0460","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08916930701510848","article-title":"PTPN22: Its role in SLE and autoimmunity","volume":"40","author":"Chung","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103611_bb0465","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8564650","article-title":"Integrative bioinformatics analysis identifies DDX60 as a potential biomarker for systemic lupus erythematosus","volume":"2023","author":"Chen","year":"2023","journal-title":"Dis Markers"},{"key":"10.1016\/j.autrev.2024.103611_bb0470","first-page":"1","article-title":"Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.autrev.2024.103611_bb0475","first-page":"1","article-title":"Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103611_bb0480","first-page":"1","article-title":"Random forests algorithm boosts genetic risk prediction of systemic lupus erythematosus","volume":"13","author":"Ma","year":"2022","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054514","article-title":"Application of Machine Learning Models in Systemic Lupus Erythematosus","volume":"24","author":"Ceccarelli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103611_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106373","article-title":"Differential diagnosis of systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome using machine learning and multi-omics data","volume":"152","author":"Martorell-Marug\u00e1n","year":"2023","journal-title":"Comput Biol Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13040-021-00284-5","article-title":"Machine learning approaches for the genomic prediction of rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Chung","year":"2021","journal-title":"BioData Min"},{"key":"10.1016\/j.autrev.2024.103611_bb0500","doi-asserted-by":"crossref","first-page":"152143","DOI":"10.1016\/j.semarthrit.2022.152143","article-title":"Risk prediction models for incident systemic lupus erythematosus among women in the Nurses\u2019 health study cohorts using genetics, family history, and lifestyle and environmental factors","volume":"58","author":"Cui","year":"2023","journal-title":"Semin Arthri Rheum [Internet]"},{"issue":"Suppl. 8","key":"10.1016\/j.autrev.2024.103611_bb0505","article-title":"Identification of gene signatures from RNA-seq data using Pareto-optimal cluster algorithm","volume":"12","author":"Mallik","year":"2018","journal-title":"BMC Syst Biol [Internet]"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb0510","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2019-216695","article-title":"Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus","volume":"80","author":"Wang","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103611_bb0515","doi-asserted-by":"crossref","first-page":"108612","DOI":"10.1016\/j.clim.2020.108612","article-title":"A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus","volume":"221","author":"Zhang","year":"2020","journal-title":"Clin Immunol [Internet]"},{"issue":"1838","key":"10.1016\/j.autrev.2024.103611_bb0520","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10067-022-06495-3","article-title":"Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data","author":"Zhang","year":"2023","journal-title":"Clin Rheumatol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0525","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0530","first-page":"1","article-title":"Three hematologic\/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis","volume":"19","author":"Cheng","year":"2021","journal-title":"J Transl Med [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr Opin Chem Biol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0540","doi-asserted-by":"crossref","first-page":"103001","DOI":"10.1016\/j.jaut.2023.103001","article-title":"Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression","author":"Lin","year":"2023","journal-title":"J Autoimmun [Internet]"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0545","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10067-020-05502-9","article-title":"Dysregulated microRNA expression in rheumatoid arthritis families\u2014a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls","volume":"40","author":"Renman","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1459-x","article-title":"Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects","volume":"19","author":"Anaparti","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103611_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.633201","article-title":"Serum miRNA Signature in Rheumatoid Arthritis and \u201cAt-Risk Individuals\u201d","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.autrev.2024.103611_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cells12131749","article-title":"Role of miRNAs in rheumatoid arthritis therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103611_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.790880","article-title":"A serum biomarker panel of exomiR-451a, exomiR-25-3p and soluble TWEAK for early diagnosis of rheumatoid arthritis","volume":"12","author":"Rodr\u00edguez-Muguruza","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0570","first-page":"1","article-title":"Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis","volume":"8","author":"Karouzakis","year":"2018","journal-title":"Sci Rep [Internet]"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0575","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0580","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/db12-1398","article-title":"Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms","volume":"62","author":"Nguyen","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0585","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat Rev Endocrinol [Internet]"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0590","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1210\/jc.2003-031887","article-title":"Prediction of autoantibody positivity and progression to type 1 diabetes: diabetes autoimmunity study in the Young (DAISY)","volume":"89","author":"Barker","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103611_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1447.062","article-title":"The environmental determinants of diabetes in the young (TEDDY) study","volume":"1150","author":"Rewers","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21051703","article-title":"Systematic review of polygenic risk scores for type 1 and type 2 diabetes","volume":"21","author":"Padilla-Mart\u00ednez","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0605","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1507\/endocrj.EJ22-0178","article-title":"Characteristic gene prognostic model of type 1 diabetes mellitus via machine learning strategy","volume":"70","author":"Wang","year":"2023","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0610","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/pedi.12092","article-title":"Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers","volume":"15","author":"Steck","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0615","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/pedi.12543","article-title":"Prediction of type 1 diabetes using a genetic risk model in the diabetes autoimmunity study in the Young","volume":"19","author":"Frohnert","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.autrev.2024.103611_bb0620","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1155\/2014\/694948","article-title":"CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort","volume":"2014","author":"Mattana","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0625","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/15216540500163301","article-title":"The insulin gene in type 1 diabetes","volume":"57","author":"Pugliese","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.autrev.2024.103611_bb0630","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1447.013","article-title":"STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes","volume":"1150","author":"Lee","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0635","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/hmg\/ddn342","article-title":"IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells","volume":"18","author":"Liu","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-60758-0","article-title":"Longitudinal DNA methylation differences precede type 1 diabetes","volume":"10","author":"Johnson","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0645","first-page":"1","article-title":"Application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling","volume":"8","author":"Perry","year":"2018","journal-title":"Sci Rep [Internet]"},{"issue":"17","key":"10.1016\/j.autrev.2024.103611_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175227","article-title":"Sj\u00f6gren syndrome: new insights in the pathogenesis and role of nuclear medicine","volume":"11","author":"Kelly","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb0655","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103611_bb0660","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/780436","article-title":"Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus","volume":"2012","author":"Cham","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2024.103611_bb0665","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6728694","article-title":"TNFAIP3 gene polymorphisms in three common autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients","volume":"2019","author":"Ciccacci","year":"2019","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.autrev.2024.103611_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12091483","article-title":"Exosome-derived microRNAs from mouthrinse have the potential to be novel biomarkers for sj\u00f6gren syndrome","volume":"12","author":"Yamashiro","year":"2022","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0675","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","article-title":"Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sj\u00f6gren\u2019s syndrome","volume":"141","author":"Zilahi","year":"2012","journal-title":"Immunol Lett [Internet]"},{"issue":"15","key":"10.1016\/j.autrev.2024.103611_bb0680","first-page":"4800","article-title":"The value of MiR-146a and MiR-4484 expressions in the diagnosis of anti-SSA antibody positive Sjogren syndrome and the correlations with prognosis","volume":"22","author":"Jiang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0685","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type i interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0690","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/annrheumdis-2020-219069","article-title":"Lupus or not? SLE risk probability index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus","volume":"80","author":"Adamichou","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0695","doi-asserted-by":"crossref","first-page":"103496","DOI":"10.1016\/j.autrev.2023.103496","article-title":"Machine learning application in autoimmune diseases: State of art and future prospectives","volume":"23","author":"Danieli","year":"2024","journal-title":"Autoimmun Rev [Internet]"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0700","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000513566","article-title":"Machine learning for prediction and risk stratification of lupus nephritis renal flare","volume":"52","author":"Chen","year":"2021","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0705","first-page":"3495","article-title":"Noise-immune extreme ensemble learning for early diagnosis of neuropsychiatric systemic lupus erythematosus","volume":"26","author":"Tan","year":"2022","journal-title":"Math Biosci Eng"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0710","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.41483","article-title":"Association of a Serum Protein Signature with Rheumatoid Arthritis Development","volume":"73","author":"O\u2019Neil","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0715","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2011-200968","article-title":"A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease","volume":"71","author":"Pratt","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0720","first-page":"1","article-title":"A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning","volume":"16","author":"Liu","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.autrev.2024.103611_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.638066","article-title":"Cross-tissue transcriptomic analysis leveraging machine learning approaches identifies new biomarkers for rheumatoid arthritis","volume":"12","author":"Rychkov","year":"2021","journal-title":"Front Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2024.103611_bb0730","first-page":"1.2","article-title":"Exploring the use of artificial intelligence in predicting rheumatoid arthritis, based on extremity MR scans in early arthritis and clinically suspect arthralgia patients","volume":"82","author":"Li","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0735","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10067-019-04487-4","article-title":"Detection of rheumatoid arthritis from hand radiographs using a convolutional neural network","volume":"39","author":"\u00dcreten","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0740","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10278-021-00564-w","article-title":"Automated classification of rheumatoid arthritis, osteoarthritis, and Normal hand radiographs with deep learning methods","volume":"35","author":"\u00dcreten","year":"2022","journal-title":"J Digit Imaging [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0745","first-page":"1","article-title":"Improved diagnosis of rheumatoid arthritis using an artificial neural network","volume":"12","author":"Bai","year":"2022","journal-title":"Sci Rep [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0750","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2339546","article-title":"A novel ensemble-based technique for the preemptive diagnosis of rheumatoid arthritis disease in the Eastern Province of Saudi Arabia using clinical data","volume":"2022","author":"Olatunji","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"3","key":"10.1016\/j.autrev.2024.103611_bb0755","first-page":"1","article-title":"Predicting the development of T1D and identifying its key performance indicators in children; a case-control study in Saudi Arabia","volume":"18","author":"Alazwari","year":"2023","journal-title":"PLoS One [Internet]"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0760","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1210\/clinem\/dgac225","article-title":"Integration of infant metabolite, genetic, and islet autoimmunity signatures to predict type 1 diabetes by age 6 years","volume":"107","author":"Webb-Robertson","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0765","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00430-022-00741-w","article-title":"Child type 1 diabetes associated with mother vaginal bacteriome and mycobiome","volume":"211","author":"Ruotsalainen","year":"2022","journal-title":"Med Microbiol Immunol [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0770","article-title":"Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity","volume":"101093","author":"Nakayasu","year":"2023","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.autrev.2024.103611_bb0775","article-title":"Early predictors of Sj\u00f6gren\u2019s syndrome: a machine learning approach","volume":"S378","author":"Royer","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.autrev.2024.103611_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2022.913325","article-title":"Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren\u2019s syndrome","volume":"9","author":"Wang","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0785","first-page":"1","article-title":"Development and verification of a combined diagnostic model for primary Sj\u00f6gren\u2019s syndrome by integrated bioinformatics analysis and machine learning","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103611_bb0790","first-page":"S137","article-title":"Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sj\u00f6gren\u2019s syndrome","volume":"36","author":"Baldini","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb0795","first-page":"2360","article-title":"Artificial neural network and deep learning in Sj\u00f6gren\u2019s disease: where we are and where we are going","volume":"41","author":"Baldini","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103611_bb0800","first-page":"S133","article-title":"Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sj\u00f6gren\u2019s syndrome: a novel pathogenetic scenario?","volume":"37","author":"Bartoloni","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0805","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1148\/radiol.2019182627","article-title":"Artificial intelligence for mammography and digital breast tomosynthesis: current concepts and future perspectives","volume":"293","author":"Geras","year":"2019","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0810","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17460441.2019.1621284","article-title":"Using artificial intelligence methods to speed up drug discovery","volume":"14","author":"\u00c1lvarez-Machancoses","year":"2019","journal-title":"Expert Opin Drug Discov [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0815","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision medicine, AI, and the future of personalized health care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.autrev.2024.103611_bb0820","series-title":"Int Conf Cyber Conflict, CYCON","article-title":"Hacking the AI - The Next Generation of Hijacked Systems","author":"Hartmann","year":"2020"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb0825","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1016\/S2589-7500(20)30249-1","article-title":"Addressing bias: artificial intelligence in cardiovascular medicine","volume":"2","author":"Tat","year":"2020","journal-title":"Lancet Digit Heal [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0830","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.1629","article-title":"Understanding the black-box: towards interpretable and reliable deep learning models","volume":"9","author":"Qamar","year":"2023","journal-title":"PeerJ Comput Sci"},{"key":"10.1016\/j.autrev.2024.103611_bb0835","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/S2665-9913(20)30064-3","article-title":"Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study","volume":"2","author":"Wells","year":"2020","journal-title":"Lancet Rheumatol [Internet]"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036095","article-title":"Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible *0401 mice but not arthritis-resistant *0402 mice","volume":"7","author":"Gomez","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103611_bb0845","first-page":"1","article-title":"Role of the gut microbiome in modulating arthritis progression in mice","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep [Internet]"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0850","first-page":"864","article-title":"Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease","volume":"2","author":"Matei","year":"2021","journal-title":"Med Interne"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0855","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med [Internet]"},{"key":"10.1016\/j.autrev.2024.103611_bb0860","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1155\/2011\/585497","article-title":"Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis","volume":"2011","author":"Smith","year":"2011","journal-title":"Int J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0865","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ccr3.3677","article-title":"Fecal microbiota transplantation for rheumatoid arthritis: a case report","volume":"9","author":"Zeng","year":"2021","journal-title":"Clin Case Reports"},{"key":"10.1016\/j.autrev.2024.103611_bb0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.711788","article-title":"Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era","volume":"12","author":"Ferro","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2024.103611_bb0875","article-title":"B lymphocytes: development, tolerance, and their role in autoimmunity - focus on systemic lupus erythematosus","volume":"2013","author":"Tob\u00f3n","year":"2013","journal-title":"Autoimmune Dis"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0880","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41423-020-0472-1","article-title":"Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus","volume":"18","author":"Jin","year":"2021","journal-title":"Cell Mol Immunol [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27312-6","article-title":"Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients","volume":"12","author":"Maschan","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0890","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5001\/omj.2013.10","article-title":"Vitamin D deficiency in patients with systemic lupus erythematosus","volume":"28","author":"Attar","year":"2013","journal-title":"Oman Med J"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0895","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2009.120329","article-title":"Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus [SLE] are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?","volume":"69","author":"Amital","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0900","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11926-008-0044-3","article-title":"The link between vitamin D deficiency and systemic lupus erythematosus","volume":"10","author":"Kamen","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.autrev.2024.103611_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19082355","article-title":"The impact of vitamin D on the immunopathophysiology, disease activity, and extra-musculoskeletal manifestations of systemic lupus erythematosus","volume":"19","author":"Mak","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0910","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpeds.2011.08.011","article-title":"Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis","volume":"160","author":"Robinson","year":"2012","journal-title":"J Pediatr [Internet]"},{"issue":"4","key":"10.1016\/j.autrev.2024.103611_bb0915","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/ker212","article-title":"Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis","volume":"51","author":"Mok","year":"2012","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.autrev.2024.103611_bb0920","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0961203311405703","article-title":"Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus","volume":"20","author":"Bonakdar","year":"2011","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb0925","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjms.2019.04.020","article-title":"Efficacy and safety of vitamin D supplementation in patients with systemic lupus erythematosus: a Meta-analysis of randomized controlled trials","volume":"358","author":"Zheng","year":"2019","journal-title":"Am J Med Sci [Internet]"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0930","article-title":"Effects of Vitamin D on systemic lupus erythematosus disease activity and autoimmunity: a systematic review and meta-analysis","volume":"14","author":"Irfan","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0935","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3899\/jrheum.200726","article-title":"Hydroxychloroquine suppresses interferon-inducible genes and B cell activating factor in patients with incomplete and new-onset systemic lupus erythematosus","volume":"48","author":"Lambers","year":"2021","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103611_bb0940","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103611_bb0945","first-page":"1","volume":"Supp 9","author":"Deane","year":"2022","journal-title":"Arthritis Rheumatol [Internet]"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0950","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001591","article-title":"Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: Results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis [STAPRA] trial","volume":"7","author":"Van Boheemen","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb0955","first-page":"130","article-title":"Abatacept in individuals at risk of developing rheumatoid arthritis: results from the arthritis prevention in the pre-clinical phase of RA with Abatacept (APIPPRA) trial","volume":"82","author":"Cope","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10429","key":"10.1016\/j.autrev.2024.103611_bb0960","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(23)02650-8","article-title":"Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk [ARIAA]: a randomised, international, multicentre, double-blind, placebo-controlled trial","volume":"403","author":"Rech","year":"2024","journal-title":"Lancet"},{"issue":"10348","key":"10.1016\/j.autrev.2024.103611_bb0965","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0970","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00125-020-05376-1","article-title":"Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial","volume":"64","author":"Assfalg","year":"2021","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.autrev.2024.103611_bb0975","first-page":"1","article-title":"Secondary Prevention of Diabetes Type 1 with Oral Calcitriol and Analogs, the PRECAL Study","volume":"10","author":"Papadimitriou","year":"2023","journal-title":"Children [Internet]"},{"issue":"19","key":"10.1016\/j.autrev.2024.103611_bb0980","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial","volume":"318","author":"Greenbaum","year":"2017","journal-title":"JAMA - J Am Med Assoc"},{"issue":"7","key":"10.1016\/j.autrev.2024.103611_bb0985","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, Teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103611_bb0995","first-page":"1","article-title":"Screening biomarkers for systemic lupus erythematosus based on machine learning and exploring their expression correlations with the ratios of various immune cells","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103611_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-Centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.autrev.2024.103611_bb1005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlagg","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2024.103611_bb1010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol [Internet]"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T05:11:47Z","timestamp":1732684307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":201,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1568997224001022"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103611","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103611"}}